These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


553 related items for PubMed ID: 16584440

  • 1. Additional red blood cell alloantibodies after blood transfusions in a nonhematologic alloimmunized patient cohort: is it time to take precautionary measures?
    Schonewille H, van de Watering LM, Brand A.
    Transfusion; 2006 Apr; 46(4):630-5. PubMed ID: 16584440
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Prevalence and specificities of red blood cell alloantibodies in transfused Ugandans with different diseases.
    Natukunda B, Schonewille H, van de Watering L, Brand A.
    Vox Sang; 2010 Feb; 98(2):167-71. PubMed ID: 19708889
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands.
    Koelewijn JM, Vrijkotte TG, van der Schoot CE, Bonsel GJ, de Haas M.
    Transfusion; 2008 May; 48(5):941-52. PubMed ID: 18248570
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Red blood cell alloantibodies after transfusion: factors influencing incidence and specificity.
    Schonewille H, van de Watering LM, Loomans DS, Brand A.
    Transfusion; 2006 Feb; 46(2):250-6. PubMed ID: 16441603
    [Abstract] [Full Text] [Related]

  • 12. Red blood cell alloimmunization in transfusion-dependent Egyptian patients with thalassemia in a limited donor exposure program.
    el-Danasoury AS, Eissa DG, Abdo RM, Elalfy MS.
    Transfusion; 2012 Jan; 52(1):43-7. PubMed ID: 21745214
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood.
    Vichinsky EP, Earles A, Johnson RA, Hoag MS, Williams A, Lubin B.
    N Engl J Med; 1990 Jun 07; 322(23):1617-21. PubMed ID: 2342522
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Does an alloimmune response to strong immunogenic red blood cell antigens enhance a response to weaker antigens?
    Schonewille H, Brand A.
    Transfusion; 2008 May 07; 48(5):958-63. PubMed ID: 18454736
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 28.